阴道给药领域的创新者

Callavid^® is at clinical stage for fertility and threatened miscarriage, with future applications in menopause, cancer, infectious diseases, and delivery of live biotherapeutics.

— As featured in —

患者需要创新的女性专用给药系统来改善疗效

Calla Lily Clinical Care' semi-automated machinery

嘉乐丽的新型阴道给药设备已获得专利，该设备拥有多项显著优势

“Callavid will be unbelievably popular with miscarriage patients as pessary leakage is the most frequent complaint, causing significant anxiety. The benefits of reducing psychological trauma, anxiety and depression are badly needed.”

Professor Siobhan Quenby

Director Biomedical Research Unit in Reproductive Health,
Professor of Obstetrics University of Warwick,
Deputy Director Tommy’s National Centre for Miscarriage Research,
Calla Lily Clinical Care Medical Advisor

The vagina’s huge medical potential has gone untapped, but not for much longer

“Calla Lily has developed a new leak-free vaginal drug delivery platform. It's simple to use (essential when patients have to administer medications themselves) and also helps to alleviate dosage anxiety and other stresses”

“多亏了英国国家卫生与临床优化研究所（NICE）的新流产管理指南，我们现在第一次有推荐的药物来帮助减少流产的发生率：阴道给药微粉化黄体酮。嘉乐丽临床护理的新设备解决了患者阴道给药黄体酮治疗中渗漏和不便等问题。”

Stuart Lavery 医生

伦敦大学学院医院（UCLH）女性健康部门临床主任、嘉乐丽临床护理医学顾问

“This novel platform is of great benefit to anyone using a vaginally-delivered medication. By addressing the major issue of leakage, women can be assured the device delivers the correct dose in a convenient, tidy and less invasive fashion. It is truly a transformative device.”

Dr Kelle Moley

Former Deputy Director of Reproductive Health Technologies
at the Bill & Melinda Gates Foundation,
Calla Lily Clinical Care Medical Advisor